» Articles » PMID: 31104293

Maternal Serum Levels of Angiogenic Markers and Markers of Placentation in Pregnancies Conceived with Fresh and Vitrified-warmed Blastocyst Transfer

Overview
Publisher Springer
Date 2019 May 20
PMID 31104293
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of the study was to compare the levels of angiogenic markers and markers of placentation between pregnancies conceived with fresh (ET) and vitrified-warmed blastocyst transfer (FET).

Methods: Women with singleton pregnancies resulting from fresh ET or FET during the period between 2013 and 2017 were included in this prospective observational study. Fresh ET was performed in a stimulated and FET in natural cycle. At 6-7 weeks of gestation, after ultrasound confirmation of a single gestational sac with a viable embryo, serum levels of free β-hCG, pregnancy-associated plasma protein A (PAPP-A), placental growth factor (PIGF) and fms-like tyrosine kinase (sFlt-1) were measured. Data on the patients' characteristics, pregnancy complications and outcomes were collected from a questionnaire and National Perinatal Information System of Slovenia.

Results: Among 211 pregnancies, 126 were achieved with fresh ET and 85 with FET. There were no significant differences in perinatal outcome, pregnancy complication and PIGF level between the fresh ET and FET group. Women achieving pregnancy with FET had significant higher levels of free β-hCG (40.20 ± 30.62 IU/L vs. 28.74 ± 23.52, p = 0.002), PAPP-A (0.09 ± 0.06 vs. 0.06 ± 0.05 IU/L, p = 0.004) and sFlt-1 (596.19 ± 283.06 vs. 436.53 ± 248.23 pg/L, p < 0.0001) compared to women having conceived with fresh ET. There were no significant differences in the levels of evaluated biomarkers between patients with different pregnancy outcomes and complications.

Conclusion: Levels of angiogenic markers and markers of placentation differ between pregnancies achieved with fresh ET and FET which may reflect altered implantation and early placentation with some forms of assisted reproductive technologies.

Citing Articles

The impact of fresh versus frozen-thawed embryos on maternal serum analyte levels in IVF singleton and twin pregnancies.

Peyser A, Gulersen M, Krantz D, Li X, Bornstein E, Rochelson B J Assist Reprod Genet. 2023; 41(2):473-481.

PMID: 38133878 PMC: 10894779. DOI: 10.1007/s10815-023-03007-3.


Frozen blastocysts: Assessing the importance of day 5/day 6 blastocysts or blastocyst quality.

Jiang Y, Song G, Zhang X, Miao S, Wu X Exp Ther Med. 2022; 23(5):333.

PMID: 35401807 PMC: 8987946. DOI: 10.3892/etm.2022.11262.


The expression of pregnancy-associated plasma protein-A (PAPP-A) in human blastocoel fluid-conditioned media: a proof of concept study.

Kavoussi S, Chen S, Wininger J, Lal A, Roudebush W, Lanford H J Assist Reprod Genet. 2022; 39(2):389-394.

PMID: 35013837 PMC: 8956765. DOI: 10.1007/s10815-022-02393-4.

References
1.
Vlaisavljevic V, Kovacic B, Gavric-Lovrec V, Reljic M . Simplification of the clinical phase of IVF and ICSI treatment in programmed cycles. Int J Gynaecol Obstet. 2000; 69(2):135-42. DOI: 10.1016/s0020-7292(00)00177-6. View

2.
Reis F, DAntona D, Petraglia F . Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev. 2002; 23(2):230-57. DOI: 10.1210/edrv.23.2.0459. View

3.
Hui P, Lam Y, Tang M, Ng E, Yeung W, Ho P . Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection. Prenat Diagn. 2005; 25(5):390-3. DOI: 10.1002/pd.1169. View

4.
Tul N, Novak-Antolic Z . Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Prenat Diagn. 2006; 26(13):1206-11. DOI: 10.1002/pd.1589. View

5.
Evans M, Krantz D, Hallahan T, Galen R . Meta-analysis of first trimester Down syndrome screening studies: free beta-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol. Am J Obstet Gynecol. 2007; 196(3):198-205. DOI: 10.1016/j.ajog.2006.08.001. View